Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
33,102,957
-
Share change
-
+10,238,945
-
Total reported value
-
$602,472,946
-
Price per share
-
$18.20
-
Number of holders
-
93
-
Value change
-
+$186,544,211
-
Number of buys
-
69
-
Number of sells
-
21
Institutional Holders of RA PHARMACEUTICALS INC - COM (RARX) as of Q4 2018
As of 31 Dec 2018,
RA PHARMACEUTICALS INC - COM (RARX) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,102,957 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Morgenthaler Management Partners IX, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FIRST MANHATTAN CO, CITADEL ADVISORS LLC, Vanguard Group Inc, Candriam Luxembourg S.C.A., and BAKER BROS. ADVISORS LP.
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.